C

Captor Therapeutics SA
WSE:CTX

Watchlist Manager
Captor Therapeutics SA
WSE:CTX
Watchlist
Price: 75.5 PLN
Market Cap: zł479.4m

Wall St Price Targets

CTX Price Targets Summary
Captor Therapeutics SA

Wall Street analysts forecast CTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.

Lowest Forecast
Price Target
67.67 PLN
10% Downside
Average Forecast
Price Target
68.34 PLN
9% Downside
Highest Forecast
Price Target
70.35 PLN
7% Downside
Captor Therapeutics SA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

The compound annual growth rate for Revenue over the next 4 years is 23%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CTX's stock price target?
Price Target
68.34 PLN

According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.

What is the Revenue forecast for Captor Therapeutics SA?
Projected CAGR
23%

The compound annual growth rate for Revenue over the next 4 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett